senior man striptest.png

Were you diagnosed with Skin Cancer?

Alpha DaRT Treatment - Under Clinical Trial May Help You

Treatment - Clinial Trial

alpha_logo_light (1).png

Alpha DaRT is a groundbreaking technology that enables the use of alpha radiation in a localized treatment of cancer. Our previous research has shown more than 75% complete response rate and no harsh side effects.

Having received FDA’s Breakthrough Device Designation for the treatment of SCC of the skin without curative standard of care, the Alpha DaRT is now available in a skin cancer clinical trial led by MSK Cancer Center in NY and at major medical institutions throughout the US.

This procedure involves: 

Minimal invasiveness

No costs for enrolled patients

> 75% complete response*

One time treatment (1-2h)

Local anesthesia

No significant side effects*

*based on previous published study 

 

Alpha DaRT is administered by inserting thin sources emitting alpha radiation directly into the tumor.

The entire process lasts only 2 weeks plus follow-ip visits. The seeds are usually removed from the tumor after this period, based on the judgment of the medical staff.

unitypointhealth.png
UCC-Logo.png.png
WCC-Logo-300x138.png
dermatolofy-of-seattle&bellevue.png

Participating Doctors

Dr. Noam VanderWalde

Radiation Oncologist

West Cancer Center, Memphis TN

Dr. Mark D'Andrea

Radiation Oncologist

University

Cancer & Diagnostic Center, Houston TX

Dr. Arshin Sheybani

Radiation Oncologist

UnityPoint Health, Des Moines, IA

Dr. Elie Levy

Dermatologist

Dermatology of Seattle & Bellevue, Seattle WA

Relevant types of cancers 

Irrelevant tumor locations

✓   SCC (Squamous Cell Carcinoma)

✓   BCC (Basal Cell Carcinoma)

✓   MCC (Merkel Cell Carcinoma)

✓   Melanoma

✖   Throat

✖   Brain

✖   Tumors located in internal organs   (eg, pancreas, stomach, esophagus, cervix, etc)

✖ Oral cavity

Relevant tumor locations

✓   Cheek (external)

✓   Ear

✓   Nose 

✓   Forehead

✓   Skull

✓   Limbs (hands, feet)

   Fingers

✓   Scalp

Alpha DaRT Technology 

Alpha particles are known to be very destructive to tumor cells. They cause direct damage to the DNA of malignant cells and destroy them. However, the range of alpha particles in tissue is limited. Therefore, until now, it was not possible to use alpha particles as a treatment for solid tumors.

The Alpha DaRT technology uses the diffusion of atoms that emit alpha particles within the tumor tissue, in order to overcome the limitation of their short range. This makes possible the treatment of entire tumors.

The Alpha DaRT technology is based on small amounts of radioactive radium-224 fixed to metal needles that are inserted into the tumor itself.

When radium-224 decays, it releases radioactive atoms with short lifespans that diffuse inside the tumor. These atoms emit short-range alpha radiation that damages and kills cancer cells within a short period of time. The seeds with radium are placed into the tumor with the help of a piece of thread, which is also used to remove them at the termination of treatment.

shutterstock_534603280.jpg

Check your suitability

AlphaTau_Logo.PNG

© Alpha Tau Medical Ltd.